Northern Trust’s Korsana Biosciences, Inc. Common Stock KRSA Stock Holding History

Northern Trust’s Portfolio KRSA Stock Details KRSA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-577	Closed	-$35.1K	–	4545
2023 Q1	$35.1K	Hold	577	–	–	﹤0.01%	4345
2022 Q4	$53K	Hold	577	–	–	﹤0.01%	4270
2022 Q3	$69K	Hold	577	–	–	﹤0.01%	4229
2022 Q2	$44K	Hold	577	–	–	﹤0.01%	4441
2022 Q1	$90K	Hold	577	–	–	﹤0.01%	4380
2021 Q4	$139K	Buy	577 +64	+12%	+$3.02K	﹤0.01%	4320
2021 Q3	$220K	Buy	513 +51	+11%	+$3.34K	﹤0.01%	4133
2021 Q2	$252K	Sell	462 -1,245	-73%	-$78K	﹤0.01%	4054
2021 Q1	$667K	Sell	1,707 -129	-7%	-$9.69K	﹤0.01%	3734
2020 Q4	$787K	Sell	1,836 -65	-3%	-$4.43K	﹤0.01%	3600
2020 Q3	$1.62M	Buy	1,901 +141	+8%	+$16.1K	﹤0.01%	3154
2020 Q2	$1.46M	Sell	1,760 -195	-10%	-$16.3K	﹤0.01%	3197
2020 Q1	$725K	Sell	1,955 -95	-5%	-$6.78K	﹤0.01%	3343
2019 Q4	$780K	Buy	2,050 +26	+1%	+$2.43K	﹤0.01%	3465
2019 Q3	$3.43M	Buy	2,024 +666	+49%	+$144K	﹤0.01%	2774
2019 Q2	$2.18M	Buy	+1,358	New	+$384K	﹤0.01%	3045

Other funds holding KRSA

SPC

Slate Path Capital New York $7.22B AUM 110.75% 1-Year Est. Return

MFN Partners Boston, Massachusetts $4.83B AUM 65.74% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Artal Group Luxembourg $931M AUM 41.63% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

CAPTRUST Financial Advisors Raleigh, North Carolina $65.5B AUM 24.25% 1-Year Est. Return

Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return

Northern Trust's KRSA Position: Q2 2023 in Review

Northern Trust sold out of Korsana Biosciences, Inc. Common Stock (KRSA) in Q2 2023, closing a stake of 577 shares — an estimated $35.1K sold.

Northern Trust first reported a position in KRSA in Q2 2019 and held it in 16 quarters. The position peaked at $3.43M in Q3 2019. 17 funds tracked by Wall St. Rank hold KRSA as of Q2 2023.

Northern Trust reported no remaining Korsana Biosciences, Inc. Common Stock position as of Q2 2023 after selling out during the quarter.
Northern Trust sold 577 Korsana Biosciences, Inc. Common Stock shares in Q2 2023, an estimated $35.1K.
Northern Trust first reported a position in Korsana Biosciences, Inc. Common Stock in Q2 2019 and held it in 16 quarters.
Northern Trust's Korsana Biosciences, Inc. Common Stock position peaked at $3.43M in Q3 2019.
17 funds tracked by Wall St. Rank held Korsana Biosciences, Inc. Common Stock as of Q2 2023.

Based on Northern Trust's 13F filing for Q2 2023, filed 11 Aug 2023.